Market Price

33.38 

-0.37 -1.1%

as of Jul 07 '20

52 Week Range:

14.00 34.25


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It provides its products for use in respiratory care, acute care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers myAIRVO 2, a humidifier with integrated flow source; Optiflow, a nasal high flow therapy; and noninvasive and invasive ventilation systems. It also provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. In addition, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Mar '10 Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18 Mar '19 Mar '20
Equity (BVPS) 0.44
0.44
0.46
0.52
0.63
0.72
0.72
0.95
1.13
1.30
1.56
growth rate 0.0% 4.6% 13.0% 21.2% 14.3% 0.0% 31.9% 19.0% 15.0% 20.0%
Earnings BIT 82.77
68.25
72.75
113.00
143.50
170.08
211.08
240.10
269.80
292.60
growth rate -17.5% 6.6% 55.3% 27.0% 18.5% 24.1% 13.8% 12.4% 8.5%
Avg.PE 24.27
32.05
19.05
18.98
24.45
45.33
62.91
49.11
57.43
64.49
108.33
growth rate 32.1% -40.6% -0.4% 28.8% 85.4% 38.8% -21.9% 16.9% 12.3% 68.0%
ROA 15.63
10.57
11.77
12.94
15.54
17.41
19.97
20.57
19.99
18.75
21.75
growth rate -32.4% 11.4% 9.9% 20.1% 12.0% 14.7% 3.0% -2.8% -6.2% 16.0%
ROE 28.03
17.30
19.38
21.39
24.94
25.80
28.32
28.11
26.73
24.99
30.45
growth rate -38.3% 12.0% 10.4% 16.6% 3.5% 9.8% -0.7% -4.9% -6.5% 21.9%
ROIC 20.27
14.19
15.29
16.58
20.06
23.05
26.41
25.82
24.47
22.81
27.53
growth rate -30.0% 7.8% 8.4% 21.0% 14.9% 14.6% -2.2% -5.2% -6.8% 20.7%
Cur. Ratio 1.84
2.22
1.29
2.36
1.82
2.08
1.91
2.40
2.38
2.47
1.55
growth rate 20.7% -41.9% 83.0% -22.9% 14.3% -8.2% 25.7% -0.8% 3.8% -37.3%
Quick Ratio 0.80
1.02
0.55
0.98
0.81
1.03
1.00
1.31
1.56
1.62
1.10
growth rate 27.5% -46.1% 78.2% -17.4% 27.2% -2.9% 31.0% 19.1% 3.9% -32.1%
Leverage 1.62
1.65
1.64
1.66
1.55
1.42
1.42
1.33
1.35
1.32
1.47
growth rate 1.9% -0.6% 1.2% -6.6% -8.4% 0.0% -6.3% 1.5% -2.2% 11.4%
Balance Sheet Mar '10 Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18 Mar '19 Mar '20
Acct.Receivable 1.30
80.00
78.00
83.00
94.71
109.29
133.24
131.60
147.70
159.30
growth rate 6,053.9% -2.5% 6.4% 14.1% 15.4% 21.9% -1.2% 12.2% 7.9%
Acct.Payable 21.00
23.00
21.00
23.22
27.66
36.96
29.30
32.70
55.10
growth rate 9.5% -8.7% 10.6% 19.1% 33.6% -20.7% 11.6% 68.5%
Cur.Assets 139.50
186.00
195.00
215.00
234.96
243.29
285.72
349.10
424.20
455.30
growth rate 33.3% 4.8% 10.3% 9.3% 3.6% 17.4% 22.2% 21.5% 7.3%
Total Assets 368.10
518.00
572.00
619.00
630.33
669.82
766.80
878.20
1,025.10
1,206.70
growth rate 40.7% 10.4% 8.2% 1.8% 6.3% 14.5% 14.5% 16.7% 17.7%
Cash 5.30
6.00
6.00
8.00
10.44
13.62
18.74
61.30
31.90
48.20
growth rate 13.2% 0.0% 33.3% 30.5% 30.5% 37.6% 227.1% -48.0% 51.1%
Inventory 55.60
80.00
84.00
89.00
94.48
96.14
120.95
135.00
125.40
136.10
growth rate 43.9% 5.0% 6.0% 6.2% 1.8% 25.8% 11.6% -7.1% 8.5%
Cur.Liabilities 75.80
84.00
151.00
91.00
128.79
117.11
149.52
145.60
178.40
184.40
growth rate 10.8% 79.8% -39.7% 41.5% -9.1% 27.7% -2.6% 22.5% 3.4%
Liabilities 140.90
204.00
224.00
246.00
224.20
198.63
225.13
216.60
263.70
293.50
growth rate 44.8% 9.8% 9.8% -8.9% -11.4% 13.4% -3.8% 21.8% 11.3%
LT Debt 46.20
85.00
40.00
123.00
66.08
55.40
50.82
40.30
52.70
69.30
growth rate 84.0% -52.9% 207.5% -46.3% -16.2% -8.3% -20.7% 30.8% 31.5%
Equity 227.20
230.40
274.40
298.60
406.12
471.19
541.67
661.60
761.40
913.20
growth rate 1.4% 19.1% 8.8% 36.0% 16.0% 15.0% 22.1% 15.1% 19.9%
Common Shares 531.00
535.00
548.00
558.00
558.00
569.00
571.00
573.00
576.00
578.00
579.00
growth rate 0.8% 2.4% 1.8% 0.0% 2.0% 0.4% 0.4% 0.5% 0.4% 0.2%
Cash Flow Statement Mar '10 Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18 Mar '19 Mar '20
Capital Expenditures 35.40
41.00
65.00
59.00
27.31
39.27
48.02
47.90
83.20
115.40
growth rate 15.8% 58.5% -9.2% -53.7% 43.8% 22.3% -0.2% 73.7% 38.7%
Cash Dividends 52.80
50.50
55.30
57.00
36.14
42.81
61.20
79.90
91.80
101.00
growth rate -4.4% 9.5% 3.1% -36.6% 18.5% 42.9% 30.6% 14.9% 10.0%
Cash From OA 106.50
71.00
94.00
86.00
99.50
146.83
144.57
193.60
247.80
253.30
growth rate -33.3% 32.4% -8.5% 15.7% 47.6% -1.5% 33.9% 28.0% 2.2%
FCF per Share 0.13
0.04
0.07
0.04
0.08
0.16
0.09
0.20
0.19
0.25
0.19
growth rate -69.2% 75.0% -42.9% 100.0% 100.0% -43.8% 122.2% -5.0% 31.6% -24.0%
Sale Purchase of Stock 0.65
2.11
1.57
1.60
1.80
growth rate 222.5% -25.6% 1.9% 12.5%
FCF 69.00
28.00
26.00
24.00
72.00
93.00
79.00
131.00
149.00
120.00
150.00
growth rate -59.4% -7.1% -7.7% 200.0% 29.2% -15.1% 65.8% 13.7% -19.5% 25.0%
Income Statement Mar '10 Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18 Mar '19 Mar '20
Sales 367.90
506.00
517.00
556.00
623.45
672.35
815.49
894.40
980.80
1,070.40
growth rate 37.5% 2.2% 7.5% 12.1% 7.8% 21.3% 9.7% 9.7% 9.1%
Op.Income 54.20
52.00
64.00
113.00
143.50
170.08
211.08
240.10
269.80
292.60
growth rate -4.1% 23.1% 76.6% 27.0% 18.5% 24.1% 13.8% 12.4% 8.5%
IBT 82.80
68.20
72.70
87.80
136.66
158.77
200.83
238.50
267.80
291.20
growth rate -17.6% 6.6% 20.8% 55.7% 16.2% 26.5% 18.8% 12.3% 8.7%
Net Income 55.50
52.00
64.00
77.00
97.05
113.17
143.43
169.20
190.20
209.20
growth rate -6.3% 23.1% 20.3% 26.0% 16.6% 26.7% 18.0% 12.4% 10.0%
EPS 0.10
0.10
0.12
0.14
0.17
0.20
0.25
0.29
0.33
0.36
0.49
growth rate 0.0% 20.0% 16.7% 21.4% 17.7% 25.0% 16.0% 13.8% 9.1% 36.1%
Gross Profit 187.50
278.00
275.00
308.00
365.40
410.98
521.65
590.40
650.40
715.80
growth rate 48.3% -1.1% 12.0% 18.6% 12.5% 26.9% 13.2% 10.2% 10.1%
R&D 27.30
28.90
33.10
36.70
54.15
64.99
73.29
86.00
94.70
100.40
growth rate 5.9% 14.5% 10.9% 47.5% 20.0% 12.8% 17.4% 10.1% 6.0%

Quarterly Statements

Item Name Sep '18 Dec '18 Mar '19 Jun '19 Sep '19
Earnings BIT 69.50
72.95
72.95
83.00
83.00
growth rate 5.0% 0.0% 13.8% 0.0%
Balance Sheet Sep '18 Dec '18 Mar '19 Jun '19 Sep '19
Acct.Receivable 153.00
159.30
159.30
162.20
162.20
growth rate 4.1% 0.0% 1.8% 0.0%
Acct.Payable 114.80
55.10
55.10
127.80
127.80
growth rate -52.0% 0.0% 131.9% 0.0%
Cur.Assets 406.40
455.30
455.30
412.00
412.00
growth rate 12.0% 0.0% -9.5% 0.0%
Total Assets 1,044.00
1,206.70
1,206.70
1,255.00
1,255.00
growth rate 15.6% 0.0% 4.0% 0.0%
Cash 55.50
48.20
48.20
48.40
48.40
growth rate -13.2% 0.0% 0.4% 0.0%
Inventory 135.40
136.10
136.10
146.30
146.30
growth rate 0.5% 0.0% 7.5% 0.0%
Cur.Liabilities 195.50
184.40
184.40
199.60
199.60
growth rate -5.7% 0.0% 8.2% 0.0%
Liabilities 267.30
293.50
293.50
336.30
336.30
growth rate 9.8% 0.0% 14.6% 0.0%
LT Debt 45.30
69.30
69.30
74.70
74.70
growth rate 53.0% 0.0% 7.8% 0.0%
Equity 776.70
913.20
913.20
918.70
918.70
growth rate 17.6% 0.0% 0.6% 0.0%
Common Shares 213.30
221.00
221.00
223.20
223.20
growth rate 3.6% 0.0% 1.0% 0.0%
Cash Flow Statement Sep '18 Dec '18 Mar '19 Jun '19 Sep '19
Capital Expenditures 26.85
30.85
30.85
36.70
36.70
growth rate 14.9% 0.0% 19.0% 0.0%
Cash Dividends 31.70
18.80
18.80
31.91
31.91
growth rate -40.7% 0.0% 69.7% 0.0%
Cash From OA 46.70
79.95
79.95
56.75
56.75
growth rate 71.2% 0.0% -29.0% 0.0%
Sale Purchase of Stock
growth rate
FCF 19.85
49.10
49.10
20.05
20.05
growth rate 147.4% 0.0% -59.2% 0.0%
Income Statement Sep '18 Dec '18 Mar '19 Jun '19 Sep '19
Sales 255.65
279.55
279.55
285.45
285.45
growth rate 9.4% 0.0% 2.1% 0.0%
Op.Income 69.50
72.95
72.95
83.00
83.00
growth rate 5.0% 0.0% 13.8% 0.0%
IBT 67.95
77.65
77.65
79.85
79.85
growth rate 14.3% 0.0% 2.8% 0.0%
Net Income 48.70
55.90
55.90
60.60
60.60
growth rate 14.8% 0.0% 8.4% 0.0%
Gross Profit 170.80
187.10
187.10
191.45
191.45
growth rate 9.5% 0.0% 2.3% 0.0%
R&D 22.85
27.35
27.35
27.00
27.00
growth rate 19.7% 0.0% -1.3% 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

A+ (92.31)

YOY Growth Grade:

B (69.06)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 108.33 136.24 75.83
EPS / Growth 21.9% 0.25 11.7%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 18.5%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 11.7% 17.4% 17.4%
Future PE 23.46 72.98 72.98
Future EPS 0.74 1.22 1.22
Value Price
MOS %
4.31
-87.1%
21.96
-34.2%
21.96
-34.2%
MOS Price 2.15 10.98 10.98
IRT 24.58 19.04 19.04

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.